Aprea Therapeutics, Inc.
News
Aprea Therapeutics to Present at the Life Sciences Investor Forum on September 19
Globe Newswire Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.comDOYLESTOWN, Pa., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Aprea...\n more…
UPDATE - Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
Globe Newswire DOYLESTOWN, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) ( Aprea or the Company ), a clinical stage biopharmaceutical company focused on precision oncology...\n more…
Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
Globe Newswire DOYLESTOWN, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) ( Aprea or the Company ), a clinical stage biopharmaceutical company focused on precision oncology...\n more…
Aprea Therapeutics closing in on third experimental cancer treatment
Bizjournals.com - Health Care News A former Penn researcher turned a "simple" experiment into an $18 million cancer-fighting biopharma firm. Aprea Therapeutics currently has two new drug candidates targeting cancer in clinical testing, with a third in the works.\n more…
Aprea Therapeutics to Present at the H.C. Wainwright Annual Global Investment Conference
Globe Newswire DOYLESTOWN, Pa., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) ( Aprea or the Company ), a clinical stage biopharmaceutical company focused on precision oncology...\n more…
